 | • レポートコード：B-MOR-05043 • 出版社/出版日：Mordor Intelligence / 2018年4月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、アテレクトミー装置の世界市場について調べ、アテレクトミー装置の世界規模、市場動向、市場環境、製品別分析、用途別分析、エンドユーザー別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・アテレクトミー装置の世界市場インサイト ・アテレクトミー装置の世界市場環境 ・アテレクトミー装置の世界市場動向 ・アテレクトミー装置の世界市場規模 ・アテレクトミー装置の世界市場規模：製品別 ・アテレクトミー装置の世界市場規模：用途別 ・アテレクトミー装置の世界市場規模：エンドユーザー別 ・アテレクトミー装置の世界市場：地域別市場規模・分析 ・アテレクトミー装置の北米市場規模・予測 ・アテレクトミー装置のアメリカ市場規模・予測 ・アテレクトミー装置のヨーロッパ市場規模・予測 ・アテレクトミー装置のアジア市場規模・予測 ・アテレクトミー装置のインド市場規模・予測 ・アテレクトミー装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
Atherectomy Devices Market – Segmented by Product, Application, End-User and Geography – Growth, Trends, and Forecast (2018 – 2023)
Keywords: atherectomy devices market
Meta Description: The atherectomy devices market is projected to grow, at a CAGR of about 6.1%.
Meta title: Atherectomy Devices Market | Growth, Trends and Forecasts (2018-2023)
The atherectomy devices market is projected to grow, at a CAGR of about 6.1%. Atherectomy is a minimally invasive endovascular procedure generally performed to remove atherosclerosis from blood vessels within the body. A few types of atherectomy include, laser, directional and rotational atherectomy.
Rising Demand for Minimally Invasive Surgical Procedures
In minimally invasive surgery, doctors use variety of ways to operate with minimal damage to the body as opposed to traditional open surgery. In general, minimally invasive surgery is associated with less pain, a shorter hospital stay and fewer complications. Atherectomy is a minimally invasive procedure generally used to treat arteries it can be used in veins and vascular bypass grafts as well. The demand for this surgery is growing up at a very high rate due to several factors that include less pain, shorter hospital stay, less scarring, less injury to tissue and higher accuracy rate. This will lead to a high CAGR with which the market is expected to grow in the forecast period. Along with this, there are other factors such as continuous product development and commercialization, favorable medical reimbursement scenario in mature markets and strengthening distribution channels of major product manufacturers will lead to the growth of the atherectomy devices market.
Lack of Well-Trained Surgeons
Since Surgical Specialists are one of the primary users of minimally invasive devices, many countries are facing shortage of such healthcare professionals. Due to this shortage, patients who are willing to opt for a minimally invasive procedure like atherectomy have to reluctantly undergo conventional procedures. Both of these factors are limiting the scope this market drastically. Hospitals with high patient enrollments are also facing this problem in spite of possessing the purchasing power, these hospitals cannot install such devices. In many countries, rural population contributes the majority percentage towards total population. This shortage is more acute in rural regions where most of the healthcare centers are owned by the state. Government schemes are funding heavily to improve to the status of health in rural regions but minimally invasive devices category is unable to utilize this opportunity due to shortage of experienced professionals who possess the expertise to operate such devices. This will lead to the slowdown of the growth of this market along with other factors such as, stringent regulatory scenario will also lead to the slowdown of the market growth.
North America to Command Dominance
North America is expected to command the largest share of the market. Factors such as increasing availability of reimbursements for atherectomy systems, growing adoption of atherectomy systems among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials (that aim to evaluate the therapeutic efficacy of atherectomy systems in specific disease treatment) are driving the growth of the North American atherectomy devices market.
Image Here
Key Developments:
• January 2018 – Avinger, a developer of treatments for peripheral artery disease (PAD), has announced the first use of their next generation Pantheris lumivascular atherectomy system. The device was used by vascular surgeon Arne Schwindt to treat patients at St Franziskus Hospital in Münster, Germany.
Major Players: Abbott Laboratories, Avinger, B. Braun Group, Biomerics, Biotronik, Boston Scientific, C.R. Bard, Cardinal Health, Cardiovascular Systems, Koninklijke Philips, Medtronic, Minnetronix, Inc., RA Medical Systems, Straub Medical and Terumo Corporation amongst others.
Reasons to Purchase the Report
• Current and future atherectomy devices market outlook in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Market Dynamics
6.1 Market Drivers
6.1.1 Continuous Product Development and Commercialization
6.1.2 Favorable Medical Reimbursement Scenario in Mature Markets
6.1.3 Rising Demand for Minimally Invasive Surgical Procedures
6.1.4 Strengthening Distribution Channels of Major Product Manufacturers
6.2 Market Restraints
6.2.1 Stringent Regulatory Scenario
6.2.2 Lack of Well-trained Surgeons
7. Market Segmentation
7.1 By Product
7.1.1 Directional Atherectomy Systems
7.1.2 Orbital Atherectomy Systems
7.1.3 Photo-Ablative (Laser) Atherectomy Systems
7.1.4 Rotational Atherectomy Systems
7.2 By Application
7.2.1 Peripheral Vascular Applications
7.2.2 Cardiovascular Applications
7.2.3 Neurovascular Applications
7.3 By End User
7.3.1 Hospitals & Surgical Centers
7.3.2 Ambulatory Care Centers
7.3.3 Research Laboratories & Academic Institutes
7.3.4 Others
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 India
7.4.3.2 Australia & New Zealand
7.4.3.3 South Korea
7.4.3.4 Rest of Asia-Pacific
7.4.4 Rest of the World
7.4.4.1 Saudi Arabia
7.4.4.2 Brazil
7.4.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott Laboratories
9.2 Avinger
9.3 B. Braun Group
9.4 Biomerics
9.5 Biotronik
9.6 Boston Scientific
9.7 C.R. Bard
9.8 Cardinal Health
9.9 Cardiovascular Systems
9.10 Koninklijke Philips
9.11 Medtronic
9.12 Minnetronix Inc.
9.13 RA Medical Systems
9.14 Straub Medical
9.15 Terumo Corporation
*List not Exhaustive
10. Future of the Market